RU96101967A - Раствор кровезаменителя на водной основе и способ его получения - Google Patents
Раствор кровезаменителя на водной основе и способ его полученияInfo
- Publication number
- RU96101967A RU96101967A RU96101967/14A RU96101967A RU96101967A RU 96101967 A RU96101967 A RU 96101967A RU 96101967/14 A RU96101967/14 A RU 96101967/14A RU 96101967 A RU96101967 A RU 96101967A RU 96101967 A RU96101967 A RU 96101967A
- Authority
- RU
- Russia
- Prior art keywords
- solution
- solution according
- carboxylic acid
- organic carboxylic
- present
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 6
- 239000011734 sodium Substances 0.000 claims 5
- 150000001735 carboxylic acids Chemical class 0.000 claims 4
- 239000003633 blood substitute Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N Citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 1
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Natural products CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 150000002402 hexoses Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 239000003058 plasma substitute Substances 0.000 claims 1
- 150000004717 pyruvic acids Chemical class 0.000 claims 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical group [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
- 229910052708 sodium Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
Claims (10)
1. Раствор кровезаменителя на водной основе, отличающийся тем, что содержит онкотический агент, К+ не более 5 мМ, Na+, органическую карбоновую кислоту, ее соль или эфир.
2. Раствор по п.1, отличающийся тем, что дополнительно содержит -Na+, Mg+ +, Ca+ + +, Cl- в физиологических или субфизиологических концентрациях, сахар.
3. Раствор по п.2, отличающийся тем, что К+ присутствует в пределах концентраций 2 - 3 мМ.
4. Раствор по п.2, отличающийся тем, что Na+ присутствует в пределах концентраций 130 - 150 мМ, Mg+ + присутствует в пределах концентраций 0,20 - 0,45 мМ, Ca+ + присутствует в концентрации 2,0 - 2,5 мМ и сахар представляет собой простой гексозный сахар, выбранный из группы, состоящей из глюкозы, фруктозы или галактозы или их смеси.
5. Раствор по п.2, отличающийся тем, что указанные органическая карбоновая кислота, ее соль или эфир представлены формулой
RCOOX,
где R - алкил, алкенил или арил, имеющие разветвленную или прямую цепь, содержащую 1 - 30 атомов углерода, которые могут быть замещенными;
Х - водород, или натрий, или другой биологически совместимый ионный заместитель, который может присоединяться в положении кислорода, или Х обозначает прямой или разветвленный алкил с короткой цепью, содержащей 1 - 4 атома углерода.
RCOOX,
где R - алкил, алкенил или арил, имеющие разветвленную или прямую цепь, содержащую 1 - 30 атомов углерода, которые могут быть замещенными;
Х - водород, или натрий, или другой биологически совместимый ионный заместитель, который может присоединяться в положении кислорода, или Х обозначает прямой или разветвленный алкил с короткой цепью, содержащей 1 - 4 атома углерода.
6. Раствор по п.5, отличающийся тем, что органическая карбоновая кислота выбрана из группы, состоящей из молочной, уксусной, пировиноградной или лимонной кислот.
7. Раствор по п.3, отличающийся тем, что дополнительно содержит NaHCO3.
8. Способ получения стерилизованного нагреванием кровезаменителя, включающий помещение раствора, содержащего не более 5 мМ К+, Na+, Mg+ +, Ca+ +, Cl- при физиологических или субфизиологических уровнях концентраций, макромолекулярный онкотический агент, органическую карбоновую кислоту, ее соль или эфир, в стерилизуемый нагреванием контейнер, и повышение температуры этого раствора под давлением и в течение периода времени, достаточных, чтобы убить всех или фактически всех бактерий и инактивировать всех или фактически всех вирусов в этом растворе.
9. Способ по п.8, отличающийся тем, что указанный раствор вливают в субъекта в качестве кровезаменителя или плазмозаменителя.
10. Способ по п.8, отличающийся тем, что указанный раствор содержит не более 5 мМ К+.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/071,533 | 1993-06-04 | ||
US08/071.533 | 1993-06-04 | ||
US08/071,533 US5407428A (en) | 1993-06-04 | 1993-06-04 | Solutions for use as plasma expanders and substitutes |
US08/133.527 | 1993-10-07 | ||
US08/133,527 | 1993-10-07 | ||
US13352793A | 1993-10-08 | 1993-10-08 | |
PCT/US1994/006279 WO1994028950A1 (en) | 1993-06-04 | 1994-06-03 | Plasma-like solution |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96101967A true RU96101967A (ru) | 1998-03-27 |
RU2142282C1 RU2142282C1 (ru) | 1999-12-10 |
Family
ID=26752331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96101967A RU2142282C1 (ru) | 1993-06-04 | 1994-06-03 | Раствор кровезаменителя на водной основе и способ его получения |
Country Status (17)
Country | Link |
---|---|
US (14) | US5702880A (ru) |
EP (1) | EP0701455B1 (ru) |
JP (1) | JP3715312B2 (ru) |
KR (1) | KR100267604B1 (ru) |
CN (1) | CN1102851C (ru) |
AT (1) | ATE199626T1 (ru) |
AU (1) | AU681675B2 (ru) |
BR (1) | BR9406742A (ru) |
CA (1) | CA2164321C (ru) |
DE (1) | DE69426879T2 (ru) |
DK (1) | DK0701455T3 (ru) |
ES (1) | ES2157260T3 (ru) |
GR (1) | GR3036013T3 (ru) |
HK (1) | HK1010698A1 (ru) |
PT (1) | PT701455E (ru) |
RU (1) | RU2142282C1 (ru) |
WO (1) | WO1994028950A1 (ru) |
Families Citing this family (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6300322B1 (en) * | 1993-06-04 | 2001-10-09 | Biotime, Inc. | Plasma-like solution |
US5945272A (en) * | 1993-06-04 | 1999-08-31 | Biotime, Incorporated | Plasma expanders and blood substitutes |
US6627393B2 (en) * | 1993-06-04 | 2003-09-30 | Biotime, Inc. | Solutions for use as plasma expanders and substitutes |
US6680305B1 (en) * | 1993-06-04 | 2004-01-20 | Biotime, Inc. | Physiologically acceptable aqueous solutions and methods for their use |
BR9406742A (pt) | 1993-06-04 | 1996-03-12 | Biotime Inc | Solução semelhante ao plasma |
US6218099B1 (en) * | 1994-06-03 | 2001-04-17 | Biotime, Inc. | Methods and compositions for use in perfusion applications |
US5827640A (en) * | 1996-06-14 | 1998-10-27 | Biostore New Zealand Limited | Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose |
US6060233A (en) * | 1996-06-14 | 2000-05-09 | Biostore New Zealand, Ltd | Methods for the lyophilization of platelets, platelet membranes or erythrocytes |
US6040132A (en) * | 1996-06-14 | 2000-03-21 | Biostore New Zealand, Ltd. | Methods for the lyophilization of living biological materials |
US6387069B1 (en) * | 1996-09-23 | 2002-05-14 | Dsu Medical Corporation | Blood set priming method and apparatus |
US7166084B2 (en) * | 1996-09-23 | 2007-01-23 | Dsu Medical Corporation | Blood set priming method and apparatus |
US5804551A (en) * | 1996-11-12 | 1998-09-08 | Baxter International Inc. | Pretraumatic use of hemoglobin |
US5814601A (en) * | 1997-02-28 | 1998-09-29 | The Regents Of The University Of California | Methods and compositions for optimization of oxygen transport by cell-free systems |
ATE302019T1 (de) | 1997-02-28 | 2005-09-15 | Univ California | Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen |
AU6865298A (en) * | 1997-03-17 | 1998-10-12 | Boris Rubinsky | The use of cryoprotective agent compounds during cryosurgery |
US5834178C1 (en) * | 1997-07-09 | 2002-04-23 | Univ Wayne State | Flush-storage solution for donor organs |
US8409846B2 (en) * | 1997-09-23 | 2013-04-02 | The United States Of America As Represented By The Department Of Veteran Affairs | Compositions, methods and devices for maintaining an organ |
US6117166A (en) * | 1997-10-27 | 2000-09-12 | Winston; Thomas R. | Apparatus and methods for grafting blood vessel tissue |
SK6282000A3 (en) * | 1997-10-31 | 2001-02-12 | Biotime Inc | Physiologically acceptable aqueous solutions and methods for their use |
CN1068778C (zh) * | 1998-05-15 | 2001-07-25 | 赵超英 | 救治用的药物组合物及其制备方法 |
CA2352376C (en) * | 1998-11-25 | 2009-12-22 | William F. Aftoora | Liquefied water soluble acidity-reducing formulation for food and beverage products |
US6706309B1 (en) | 1998-11-25 | 2004-03-16 | William F. Aftoora | Liquefied water soluble acidity-reducing formulation for food and beverage products |
US6589223B1 (en) * | 1999-02-03 | 2003-07-08 | Biotime, Inc. | Method and compositions for use in perfusion applications |
US6755811B1 (en) * | 1999-08-25 | 2004-06-29 | Corazon Technologies, Inc. | Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue |
US6846842B2 (en) | 1999-10-07 | 2005-01-25 | Beth Israel Deconess Medical Center, Inc. | Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
US6759230B1 (en) * | 1999-10-26 | 2004-07-06 | The Board Of Regents, The University Of Texas | Microbe, microbial exopolysaccharide, and uses thereof |
US6492103B1 (en) | 2000-01-31 | 2002-12-10 | Organ Recovery Systems, Inc. | System for organ and tissue preservation and hypothermic blood substitution |
EP1398038B2 (en) * | 2000-02-08 | 2011-01-26 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions |
US8632785B2 (en) * | 2000-02-08 | 2014-01-21 | Allergan, Inc. | Clostridial toxin pharmaceutical composition containing a gelatin fragment |
US20030118598A1 (en) * | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
US20060269575A1 (en) * | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US20010048951A1 (en) * | 2000-04-14 | 2001-12-06 | Hal Sternberg | Methods of administering a synthetic plasma like solution, and systems and kits for use in practicing the same |
AU7907301A (en) * | 2000-07-28 | 2002-02-13 | Christopher J Murphy | Transplant media |
DE60121027T3 (de) | 2000-11-03 | 2011-06-09 | Xvivo Perfusion Ab | Lösung zur evaluierung und konservierung |
US6746836B1 (en) * | 2000-12-08 | 2004-06-08 | Abe Widra | Alpha-keratose as a blood plasma expander and use thereof |
US6864231B2 (en) * | 2001-01-09 | 2005-03-08 | Pharmachem Laboratories, Inc. | Glycoprotein matrix compositions and methods related thereto |
US6806069B2 (en) | 2001-01-09 | 2004-10-19 | Pharmachem Laboratories, Inc. | Ubiquinone composition and methods related thereto |
AU2002254525B2 (en) * | 2001-04-04 | 2004-12-23 | Critical Therapeutics, Inc. | Method for preventing acute renal failure |
WO2002101018A2 (en) * | 2001-06-11 | 2002-12-19 | Fred Hutchinson Cancer Research Center | Methods for inducing reversible stasis |
US20070213793A1 (en) * | 2001-08-06 | 2007-09-13 | Radiant Medical, Inc. | Use of endovascular hypothermia in organ and/or tissue transplantations |
US20070160645A1 (en) * | 2001-10-25 | 2007-07-12 | Jakob Vinten-Johansen | PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs |
ES2316618T3 (es) | 2001-10-25 | 2009-04-16 | Emory University | Cateter para perfusion modificada. |
US20030153491A1 (en) * | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
US20050164915A1 (en) * | 2002-04-01 | 2005-07-28 | Sangart, Inc. | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
EP1494659B1 (en) * | 2002-04-17 | 2005-10-12 | Critical Therapeutics, Inc. | Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt |
JP3912206B2 (ja) * | 2002-07-05 | 2007-05-09 | 株式会社日立製作所 | 筒内直接燃料噴射装置用燃料ポンプ |
US20070029259A1 (en) * | 2003-02-04 | 2007-02-08 | Hirotaka Kakita | Method of reducing impurity content in aqueous salt solution |
NZ543201A (en) * | 2003-05-01 | 2007-05-31 | Innogene Kalbiotech Pte Ltd | Lactate containing pharmaceutical composition and uses thereof |
PL1732953T3 (pl) * | 2004-03-01 | 2008-04-30 | Braun Melsungen Ag | Hydroksyetyloskrobia |
GB0407583D0 (en) * | 2004-04-05 | 2004-05-05 | Arbab Tarig S M | Diagnostic testing and related matters |
WO2007001339A2 (en) | 2004-08-17 | 2007-01-04 | Wake Forest University Health Sciences | Ambient stored blood plasma expanders |
US8304181B2 (en) | 2004-10-07 | 2012-11-06 | Transmedics, Inc. | Method for ex-vivo organ care and for using lactate as an indication of donor organ status |
NZ591524A (en) | 2004-10-07 | 2012-09-28 | Transmedics Inc | Method for timing pulsatile flow of normothermic perfusate to the heart in ex-vivo organ care |
US9301519B2 (en) | 2004-10-07 | 2016-04-05 | Transmedics, Inc. | Systems and methods for ex-vivo organ care |
JP2008525468A (ja) * | 2004-12-22 | 2008-07-17 | エモリー・ユニバーシティ | ポストコンディショニング臓器保護作用を増強する治療補助薬 |
WO2006110552A2 (en) * | 2005-04-12 | 2006-10-19 | Cleo Cosmetic And Pharmaceutical Co., Llc | Composition and method for in vitro preservation of corneal tissues |
US8822535B2 (en) * | 2005-04-20 | 2014-09-02 | Fred Hutchinson Cancer Research Center | Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms |
US9078428B2 (en) * | 2005-06-28 | 2015-07-14 | Transmedics, Inc. | Systems, methods, compositions and solutions for perfusing an organ |
EP1946763B1 (en) * | 2005-11-08 | 2013-08-21 | Ajinomoto Co., Inc. | Promoter for recovery from anesthesia |
US7854754B2 (en) | 2006-02-22 | 2010-12-21 | Zeltiq Aesthetics, Inc. | Cooling device for removing heat from subcutaneous lipid-rich cells |
US20090285909A1 (en) * | 2006-04-03 | 2009-11-19 | Leverve Xavier M | Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof |
DK3178319T3 (da) | 2006-04-19 | 2020-02-03 | Transmedics Inc | Systemer til ex vivo-organpleje |
US9132031B2 (en) | 2006-09-26 | 2015-09-15 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US20080077201A1 (en) | 2006-09-26 | 2008-03-27 | Juniper Medical, Inc. | Cooling devices with flexible sensors |
US8192474B2 (en) | 2006-09-26 | 2012-06-05 | Zeltiq Aesthetics, Inc. | Tissue treatment methods |
US9457179B2 (en) | 2007-03-20 | 2016-10-04 | Transmedics, Inc. | Systems for monitoring and applying electrical currents in an organ perfusion system |
US20080287839A1 (en) | 2007-05-18 | 2008-11-20 | Juniper Medical, Inc. | Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator |
GB0712833D0 (en) * | 2007-07-03 | 2007-08-08 | Aqix Ltd | Body Fluid Expander |
US8523927B2 (en) | 2007-07-13 | 2013-09-03 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
ES2693430T3 (es) | 2007-08-21 | 2018-12-11 | Zeltiq Aesthetics, Inc. | Monitorización del enfriamiento de células subcutáneas ricas en lípidos, como el enfriamiento de tejido adiposo |
US20090123436A1 (en) * | 2007-11-08 | 2009-05-14 | Surmodics, Inc. | Cryopreservative compositions and methods |
US8420380B2 (en) | 2008-01-31 | 2013-04-16 | Transmedics, Inc. | Systems and methods for ex vivo lung care |
US20090263780A1 (en) * | 2008-04-17 | 2009-10-22 | Yanming Wang | Organ preservation fluid |
US8275442B2 (en) | 2008-09-25 | 2012-09-25 | Zeltiq Aesthetics, Inc. | Treatment planning systems and methods for body contouring applications |
US8603073B2 (en) | 2008-12-17 | 2013-12-10 | Zeltiq Aesthetics, Inc. | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
CN101444526B (zh) * | 2008-12-30 | 2012-06-27 | 杭州民生药业有限公司 | 一种药物组合物 |
AU2010242785B2 (en) | 2009-04-30 | 2014-03-06 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
SE534527C2 (sv) * | 2009-09-24 | 2011-09-20 | Vivoline Medical Ab | Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning |
DE102009045589A1 (de) * | 2009-10-12 | 2011-04-14 | Universitätsklinikum Freiburg | Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall |
EP2528560A1 (en) | 2010-01-25 | 2012-12-05 | Zeltiq Aesthetics, Inc. | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associated devices, systems and methods |
WO2011160012A1 (en) * | 2010-06-17 | 2011-12-22 | The Trustees Of Columbia University In The City Of New York | Tissue culture media containing trimethylamine n-oxide |
US8676338B2 (en) | 2010-07-20 | 2014-03-18 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
IT1401386B1 (it) * | 2010-07-30 | 2013-07-18 | Eurotech S P A | Dispositivo di raffreddamento a liquido per schede elettroniche, in particolare per unita' di elaborazione ad elevate prestazioni |
GB201020300D0 (en) | 2010-11-30 | 2011-01-12 | Vitrolife Sweden Ab | Product |
US10722395B2 (en) | 2011-01-25 | 2020-07-28 | Zeltiq Aesthetics, Inc. | Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells |
US9253976B2 (en) | 2011-03-15 | 2016-02-09 | Paragonix Technologies, Inc. | Methods and devices for preserving tissues |
US8828710B2 (en) | 2011-03-15 | 2014-09-09 | Paragonix Technologies, Inc. | System for hypothermic transport of samples |
US9867368B2 (en) | 2011-03-15 | 2018-01-16 | Paragonix Technologies, Inc. | System for hypothermic transport of samples |
US9426979B2 (en) | 2011-03-15 | 2016-08-30 | Paragonix Technologies, Inc. | Apparatus for oxygenation and perfusion of tissue for organ preservation |
EP2685814B1 (en) | 2011-03-15 | 2016-08-17 | Paragonix Technologies, Inc. | Apparatus for oxygenation and perfusion of tissue for organ preservation |
US11178866B2 (en) | 2011-03-15 | 2021-11-23 | Paragonix Technologies, Inc. | System for hypothermic transport of samples |
AU2012242578B2 (en) | 2011-04-14 | 2016-07-21 | Transmedics, Inc. | Organ care solution for ex-vivo machine perfusion of donor lungs |
CN102488942B (zh) * | 2011-11-22 | 2013-03-20 | 安徽双鹤药业有限责任公司 | 回血试验方法及其回血试验装置 |
US20130330706A1 (en) * | 2012-06-06 | 2013-12-12 | Evan C. Unger | Fluid for Suspended Animation |
US8785116B2 (en) | 2012-08-10 | 2014-07-22 | Paragonix Technologies, Inc. | Methods for evaluating the suitability of an organ for transplant |
US9560846B2 (en) | 2012-08-10 | 2017-02-07 | Paragonix Technologies, Inc. | System for hypothermic transport of biological samples |
US9545523B2 (en) | 2013-03-14 | 2017-01-17 | Zeltiq Aesthetics, Inc. | Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue |
US9844460B2 (en) | 2013-03-14 | 2017-12-19 | Zeltiq Aesthetics, Inc. | Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same |
WO2015117026A2 (en) | 2014-01-31 | 2015-08-06 | Zeltiq Aesthetics, Inc. | Treating systems and methods for treating cellulite and providing other treatments |
US10675176B1 (en) | 2014-03-19 | 2020-06-09 | Zeltiq Aesthetics, Inc. | Treatment systems, devices, and methods for cooling targeted tissue |
USD777338S1 (en) | 2014-03-20 | 2017-01-24 | Zeltiq Aesthetics, Inc. | Cryotherapy applicator for cooling tissue |
US10952891B1 (en) | 2014-05-13 | 2021-03-23 | Zeltiq Aesthetics, Inc. | Treatment systems with adjustable gap applicators and methods for cooling tissue |
IL303658B1 (en) | 2014-06-02 | 2024-03-01 | Transmedics Inc | Extracorporeal system for organ treatment |
US10935174B2 (en) | 2014-08-19 | 2021-03-02 | Zeltiq Aesthetics, Inc. | Stress relief couplings for cryotherapy apparatuses |
US10568759B2 (en) | 2014-08-19 | 2020-02-25 | Zeltiq Aesthetics, Inc. | Treatment systems, small volume applicators, and methods for treating submental tissue |
CA3155169A1 (en) | 2014-12-12 | 2016-06-16 | Tevosol, Inc. | ORGAN PERFUSION APPARATUS AND METHOD |
US20180169139A1 (en) * | 2015-06-10 | 2018-06-21 | Cellphire, Inc. | Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia |
SG10201913250SA (en) * | 2015-08-18 | 2020-03-30 | Astellas Inst For Regenerative Medicine | Clinical formulations |
WO2017044465A1 (en) | 2015-09-09 | 2017-03-16 | Transmedics, Inc | Aortic cannula for ex vivo organ care system |
US10448631B2 (en) | 2015-09-22 | 2019-10-22 | East Carolina University | Cryopreservation using sucralose |
US11154418B2 (en) | 2015-10-19 | 2021-10-26 | Zeltiq Aesthetics, Inc. | Vascular treatment systems, cooling devices, and methods for cooling vascular structures |
WO2017120538A1 (en) | 2016-01-07 | 2017-07-13 | Zeltiq Aesthetics, Inc. | Temperature-dependent adhesion between applicator and skin during cooling of tissue |
US10765552B2 (en) | 2016-02-18 | 2020-09-08 | Zeltiq Aesthetics, Inc. | Cooling cup applicators with contoured heads and liner assemblies |
CN106092848B (zh) * | 2016-03-22 | 2018-07-06 | 威海威高血液净化制品有限公司 | 透析器超滤性能测试液 |
US11382790B2 (en) | 2016-05-10 | 2022-07-12 | Zeltiq Aesthetics, Inc. | Skin freezing systems for treating acne and skin conditions |
US10555831B2 (en) | 2016-05-10 | 2020-02-11 | Zeltiq Aesthetics, Inc. | Hydrogel substances and methods of cryotherapy |
US10682297B2 (en) | 2016-05-10 | 2020-06-16 | Zeltiq Aesthetics, Inc. | Liposomes, emulsions, and methods for cryotherapy |
US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
US10426796B2 (en) | 2016-06-13 | 2019-10-01 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
ES2651717B1 (es) * | 2016-07-26 | 2018-11-16 | Lara OLLER DUQUE | Solución acuosa cristaloide isotónica |
US20200093853A1 (en) * | 2016-12-08 | 2020-03-26 | Cellphire, Inc. | Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia |
US11076879B2 (en) | 2017-04-26 | 2021-08-03 | Zeltiq Aesthetics, Inc. | Shallow surface cryotherapy applicators and related technology |
CA3066625A1 (en) | 2017-06-07 | 2018-12-13 | Paragonix Technologies, Inc. | Apparatus for tissue transport and preservation |
AU2019315940A1 (en) | 2018-07-31 | 2021-03-04 | Zeltiq Aesthetics, Inc. | Methods, devices, and systems for improving skin characteristics |
EP3886879A4 (en) | 2018-11-30 | 2022-12-07 | Cellphire Inc. | PLATES AS DELIVERY AGENTS |
EP3887404A4 (en) | 2018-11-30 | 2022-11-02 | Cellphire, Inc. | SLIDES LOADED WITH ANTI-CANCER AGENTS |
SG11202112054WA (en) | 2019-05-03 | 2021-11-29 | Cellphire Inc | Materials and methods for producing blood products |
MX2021014874A (es) | 2019-06-03 | 2022-03-25 | Cooler Heads Care Inc | Conjunto de gorro de enfriamiento y unidad de enfriamiento. |
BR112022002892A2 (pt) | 2019-08-16 | 2022-05-24 | Cellphire Inc | Trombossomos como um agente de reversão de agente antiplaqueta |
US11632951B2 (en) | 2020-01-31 | 2023-04-25 | Paragonix Technologies, Inc. | Apparatus for tissue transport and preservation |
WO2021158622A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc. | Anti-fibrinolytic loaded platelets |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
IT202000027050A1 (it) * | 2020-11-12 | 2022-05-12 | S A L F S P A Laboratorio Farm | Soluzione colloidale per la perfusione e la conservazione ex-vivo dei polmoni |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US34077A (en) * | 1862-01-07 | Improvement in weighing-registers | ||
US3356570A (en) * | 1964-11-27 | 1967-12-05 | Trustees Of Barnes Hospital | Composition for treating shock |
US3758382A (en) * | 1968-07-26 | 1973-09-11 | Us Navy | Ve agent process of freezing blood using a hydroxyalkyl starch as cryoprotecti |
ZA702706B (en) * | 1969-04-28 | 1971-12-29 | Knox Gelatine Inc | Blood plasma substitute |
US3897550A (en) * | 1971-06-01 | 1975-07-29 | Cybersol | Method for administering water soluble drugs, nutrients and other solutes to a mammal |
US3937821A (en) * | 1971-08-21 | 1976-02-10 | Kyorin Seiyaku Kabushiki Kaisha | Plasma substitute including artificial starch and method for the preparation thereof |
US3949098A (en) * | 1974-06-05 | 1976-04-06 | Nabisco, Inc. | Nutritious orange drink concentrate, process and drink resultant therefrom |
US4001401A (en) * | 1975-02-02 | 1977-01-04 | Alza Corporation | Blood substitute and blood plasma expander comprising polyhemoglobin |
US4061736A (en) * | 1975-02-02 | 1977-12-06 | Alza Corporation | Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin |
DE2801123C2 (de) * | 1977-01-26 | 1986-01-02 | Armour Pharma GmbH & Co KG, 3440 Eschwege | Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates |
US4609372A (en) * | 1983-10-13 | 1986-09-02 | Miles Laboratories, Inc. | Heat sterilizable storage solution for red blood cells |
AU583272B2 (en) * | 1984-04-27 | 1989-04-27 | Synthetic Blood Corporation | Coacervate system synthetic whole blood substitute |
US4663166A (en) * | 1984-06-22 | 1987-05-05 | Veech Richard L | Electrolyte solutions and in vivo use thereof |
US5084377A (en) * | 1984-09-19 | 1992-01-28 | Larry Rowan | Cryogenic suspension method |
US4879283A (en) * | 1985-10-03 | 1989-11-07 | Wisconsin Alumni Research Foundation | Solution for the preservation of organs |
US4908350A (en) * | 1985-10-31 | 1990-03-13 | The Regents Of The University Of California | Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock |
US4769318A (en) * | 1986-06-03 | 1988-09-06 | Ube Industries, Ltd. | Additive solution for blood preservation and activation |
US5210083A (en) * | 1986-07-17 | 1993-05-11 | Ed. Geistlich Sohne A.G. Fur Chemische Industrie | Pharmaceutical compositions |
JPS6360931A (ja) * | 1986-08-29 | 1988-03-17 | Noboru Sato | 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法 |
US4927806A (en) * | 1987-04-23 | 1990-05-22 | The Regents Of The University Of California | Saturated salt/concentrated dextran formulation to treat hemorrhage |
WO1989005659A1 (en) * | 1987-12-24 | 1989-06-29 | Borody Thomas J | Orthostatic lavage solutions |
US5130230A (en) * | 1988-05-02 | 1992-07-14 | Cryomedical Sciences, Inc. | Blood substitute |
US4923442A (en) * | 1988-05-02 | 1990-05-08 | Cryomedical Sciences Inc. | Blood substitute |
USRE34077E (en) * | 1988-05-02 | 1992-09-22 | Cryomedical Sciences, Inc. | Blood substitute |
JPH03220201A (ja) * | 1988-11-18 | 1991-09-27 | Eisai Co Ltd | プロスタグランジン類と多糖類の結合体 |
US5252213A (en) * | 1989-06-20 | 1993-10-12 | University Of Washington | Dry dialysate composition |
US5082831A (en) * | 1989-12-05 | 1992-01-21 | Cryovita Laboratories, Inc. | Total body washout solution and method of use |
US5171526A (en) * | 1990-01-05 | 1992-12-15 | Allergan, Inc. | Ophthalmic compositions and methods for preserving and using same |
EP0523037A4 (en) * | 1990-03-30 | 1993-07-28 | Biomedical Frontiers, Inc. | Fluid resuscitation |
US5416078A (en) * | 1990-03-30 | 1995-05-16 | Biomedical Frontiers, Inc. | Fluid resuscitation |
US5248766A (en) * | 1990-08-17 | 1993-09-28 | Baxter International Inc. | Oxirane-modified hemoglobin based composition |
GB9021325D0 (en) * | 1990-10-01 | 1990-11-14 | Geistlich Soehne Ag | Chemical composition |
WO1992008349A1 (en) * | 1990-11-07 | 1992-05-29 | Baxter International Inc. | Blood platelet storage medium |
CA2066374C (en) * | 1991-04-19 | 2002-01-29 | Paul E. Segall | Solution for perfusing primates |
WO1993002653A1 (en) * | 1991-08-08 | 1993-02-18 | Segel Leigh D | Fluorocarbon blood substitute |
BR9406742A (pt) * | 1993-06-04 | 1996-03-12 | Biotime Inc | Solução semelhante ao plasma |
US5407428A (en) * | 1993-06-04 | 1995-04-18 | Biotime, Inc. | Solutions for use as plasma expanders and substitutes |
-
1994
- 1994-06-03 BR BR9406742A patent/BR9406742A/pt not_active Application Discontinuation
- 1994-06-03 US US08/253,384 patent/US5702880A/en not_active Expired - Lifetime
- 1994-06-03 EP EP94919352A patent/EP0701455B1/en not_active Expired - Lifetime
- 1994-06-03 AT AT94919352T patent/ATE199626T1/de not_active IP Right Cessation
- 1994-06-03 PT PT94919352T patent/PT701455E/pt unknown
- 1994-06-03 AU AU70525/94A patent/AU681675B2/en not_active Ceased
- 1994-06-03 KR KR1019950705531A patent/KR100267604B1/ko not_active IP Right Cessation
- 1994-06-03 WO PCT/US1994/006279 patent/WO1994028950A1/en active IP Right Grant
- 1994-06-03 RU RU96101967A patent/RU2142282C1/ru not_active IP Right Cessation
- 1994-06-03 DE DE69426879T patent/DE69426879T2/de not_active Expired - Lifetime
- 1994-06-03 CN CN94192801A patent/CN1102851C/zh not_active Expired - Lifetime
- 1994-06-03 DK DK94919352T patent/DK0701455T3/da active
- 1994-06-03 ES ES94919352T patent/ES2157260T3/es not_active Expired - Lifetime
- 1994-06-03 CA CA002164321A patent/CA2164321C/en not_active Expired - Lifetime
- 1994-06-03 JP JP50197895A patent/JP3715312B2/ja not_active Expired - Lifetime
-
1995
- 1995-05-22 US US08/446,520 patent/US5571801A/en not_active Expired - Lifetime
- 1995-06-05 US US08/462,650 patent/US5747071A/en not_active Expired - Lifetime
- 1995-06-05 US US08/463,296 patent/US5698536A/en not_active Expired - Lifetime
- 1995-06-05 US US08/465,252 patent/US5733894A/en not_active Expired - Lifetime
- 1995-06-05 US US08/462,270 patent/US5613944A/en not_active Expired - Lifetime
- 1995-06-06 US US08/471,396 patent/US5723281A/en not_active Expired - Lifetime
-
1997
- 1997-04-23 US US08/839,021 patent/US5968726A/en not_active Expired - Fee Related
- 1997-07-18 US US08/896,824 patent/US6444418B2/en not_active Expired - Fee Related
- 1997-07-18 US US08/896,823 patent/US6080538A/en not_active Expired - Lifetime
-
1998
- 1998-02-17 US US09/024,884 patent/US6110504A/en not_active Expired - Lifetime
- 1998-03-31 US US09/052,827 patent/US6410218B2/en not_active Expired - Fee Related
- 1998-11-09 HK HK98111830A patent/HK1010698A1/xx not_active IP Right Cessation
-
1999
- 1999-06-03 US US09/325,244 patent/US6406839B1/en not_active Expired - Fee Related
- 1999-08-27 US US09/384,859 patent/US6387612B1/en not_active Expired - Fee Related
-
2001
- 2001-06-08 GR GR20010400864T patent/GR3036013T3/el not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU96101967A (ru) | Раствор кровезаменителя на водной основе и способ его получения | |
JP2843438B2 (ja) | 組成物とその使用方法 | |
US5736165A (en) | In-the-eye use of chlorine dioxide-containing compositions | |
JPS56135418A (en) | Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human | |
JPS5758876A (en) | Germicide for food, raw ingredient of food, and device for processing food, and its use | |
RU2003100090A (ru) | Способ получения водных композиций действующих начал, чувствительных к окислению | |
IE48122B1 (en) | Solutions for use in a therapeutical method of treating chronic uraemic patients undergoing dialysis | |
JPS6437956A (en) | Collagen composition for repairing bone containing spontaneous bone marrow | |
Eyzaguirre et al. | Experimental myotonia and repetitive phenomena: the veratrinic effects of 2, 4-dichlorphenoxyacetate (2, 4-D) in the rat | |
DE60301878T2 (de) | Pharmazeutische zusammensetzung enthaltend ein alpha-ketoalkansäureester oder -amid und milchsäure oder ein milchsäuresalz | |
AU3226984A (en) | Aqueous, injectable solutions of cis-platimum | |
PH25587A (en) | Mixed crystals of insulin, insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals,, theu use thereof for the treatment of diabetes mellitus | |
NO884344L (no) | Fremgangsmaate for fremstilling av nye terapeutisk aktive androstanderivater. | |
JP5297815B2 (ja) | 医薬組成物 | |
DE3162614D1 (en) | Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same | |
JPS56106594A (en) | Stabilizing method of plasminogen | |
JP2563336B2 (ja) | 角膜透過促進点眼剤 | |
DE3471587D1 (en) | Derivatives of benzoic acid, process for their preparation and their use in disinfecting and conserving medicaments | |
JPH075456B2 (ja) | 点眼液 | |
KR910009687A (ko) | Nmda-저해 제약성분 | |
NO330296B1 (no) | Opplosning av N-[O-(p-pivaloyloksybenzensulfonylamino)-benzoyl]glycinmononatriumsalt-tetrahydrat og medisinsk produkt | |
JPH09176020A (ja) | 安定なヒアルロン酸ナトリウム含有溶液 | |
JPS5554855A (en) | Method of sterilizing food | |
RU2195319C2 (ru) | Дезинфицирующее средство | |
JP2720165B2 (ja) | ぶどう糖電解質配合剤 |